Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 86.50
-3.80 (-4.21%)
Mar 13, 2026, 4:03 PM CET
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 332 employees as of June 30, 2025.
Employees
332
Change
n/a
Growth
n/a
Revenue / Employee
292.13K CHF
Profits / Employee
-10.12K CHF
Market Cap
1.46B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 332 | - | - |
| Dec 31, 2024 | 322 | -3 | -0.98% |
| Dec 31, 2023 | 325 | 30 | 10.17% |
| Dec 31, 2022 | 295 | 5 | 1.72% |
| Dec 31, 2021 | 290 | 25 | 9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Lonza Group AG | 19,771 |
| Galderma Group AG | 7,676 |
| Aevis Victoria | 4,731 |
| Tecan Group AG | 3,000 |
| SKAN Group AG | 1,504 |
| PolyPeptide Group AG | 1,400 |
Cosmo Pharmaceuticals News
- 1 day ago - Cosmo Pharmaceuticals NV (CMOPF) Full Year 2025 Earnings Call Highlights: Strong Financial ... - GuruFocus
- 1 day ago - Full Year 2025 Cosmo Pharmaceuticals NV Earnings Call Transcript - GuruFocus
- 4 days ago - Cosmo Pharmaceuticals (CMOPF) Reports Revenue Decline, Sets Positive 2026 Outlook - GuruFocus
- 4 days ago - Cosmo Pharma Slips To Loss In FY25 On Weak Revenues; Stock Drops - Nasdaq